首页 | 本学科首页   官方微博 | 高级检索  
     

奥沙利铂脂质微球注射液制剂安全性评价
引用本文:王三龙,孙立,张颖丽,沈连忠,齐卫红,李欣,王秀文,李保文,李波. 奥沙利铂脂质微球注射液制剂安全性评价[J]. 食品与药品, 2010, 12(5): 174-176
作者姓名:王三龙  孙立  张颖丽  沈连忠  齐卫红  李欣  王秀文  李保文  李波
作者单位:中国药品生物制品检定所国家药物安全评价监测中心,北京,100176 
摘    要:目的 评价临床使用奥沙利铂脂质微球注射液的安全性.方法 肌肉刺激性实验:主要观察家兔注射奥沙利铂脂质微球后48 h和2周的组织病理变化;溶血性实验:观察本品在3 h内有无溶血和聚集现象;全身过敏性实验:豚鼠隔日3次腹腔注射奥沙利铂脂质微球或牛血清白蛋白V,于末次给药后第10天静脉注射本品,观察3 h内动物的变化.结果 奥沙利铂脂质微球注射液对家兔股四头肌无刺激作用,家兔红细胞无溶血现象,豚鼠未见过敏反应.结论 实验结果表明奥沙利铂脂质微球注射液安全可靠.

关 键 词:奥沙利铂  脂质微球注射液  安全性评价

Safety Evaluation of Oxaliplatin Lipid Microsphere Injection
WANG San-long,SUN Li,ZHANG Ying-li,SHEN Lian-zhong,QI Wei-hong,LI Xin,WANG Xiu-wen,LI Bao-wen,LI Bo. Safety Evaluation of Oxaliplatin Lipid Microsphere Injection[J]. Food and Drug, 2010, 12(5): 174-176
Authors:WANG San-long  SUN Li  ZHANG Ying-li  SHEN Lian-zhong  QI Wei-hong  LI Xin  WANG Xiu-wen  LI Bao-wen  LI Bo
Affiliation:WANG San-long,SUN Li,ZHANG Ying-li,SHEN Lian-zhong,QI Wei-hong,LI Xin,WANG Xiu-wen,LI Bao-wen,LI Bo(National Center for Safety Evaluation of Drugs,National Institute for the Control of Pharmaceutical & Biological Products,Beijing 100176,China)
Abstract:Objective To evaluate the preclinical safety of Oxaliplatin Lipid Microsphere Injection.Methods In the muscle stimulation test,the histopathological changes were observed in rabbits at 48 hours and 2 weeks after the administration of Oxaliplatin Lipid Microsphere Injection;in the hemolysis test,the occurrence of any hemolysis and aggregation induced by Oxaliplatin Lipid Microsphere Injection within 3 hours was observed;in the systematic allergy test,guinea pigs were intraperitoneally administered with Oxali...
Keywords:oxaliplatin  lipid microsphere injection  safety evaluation  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号